A comparative study of the protein C system in mother's blood, cord blood and amniotic fluid

Folia Histochemica et Cytobiologica

Volumn 48, Issue 2, 2010, Pages 262-266

  Uszyński, Mieczysław ^a   Uszyński, Wałdemar ^b   Zekanowska, Ewa ^a   Kuczyński, Jarosław ^c   Szymański, Marek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Regional Hospital in Włocławek   (Poland)

^c State Vocational College in Suwa ki   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; PROTEIN S; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOMODULIN;

ADULT; AMNION FLUID; ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS BLOOD; HUMAN; MATERNAL BLOOD; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

EID: 77957228757     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-10-0059-2     Document Type: Article

References (20)

1. Cabello-Gutierrez C, Manjarrez-Zavala ME, Huerta-Zepeda, Cime-Castello J, Monroy-Martinez V, Biruete-Correa B, Ruiz-Ordaz BH. Modification of the cytoprotective protein C pathway during Dengue virus infection of human endothelial vascular cells. Thromb Haemost. 2009;101:916-928.
2. Isermann B, Sood R, Pawlinski R, Zogg M, Kalloway S, Degen JL, Macman N, Weiler H. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nature Med. 2003;9:331-33.
3. Uszyński M, Sztenc S, Żekanowska E, Uszyński W. Thrombomodulin in human gestational tissues: placenta, fetal membranes and myometrium. Adv Med Sci. 2006;51:312-315.
4. Lanir N, Aharon A, Brenner B. Procoagulant and anticoagulant mechanisms in human placenta. Semin Thromb Hemost. 2003;29:175-183.
5. Svensson AM, Waters BL, Laszik ZG, Simmsons-Arnold L, Goodwin A, Beatty BG, Bovill EG. The protein C system in placental massive perivillous fibrin deposition. Blood Coagul Fibrinolysis. 2004;15:491-495.
6. Ness RB, Roberts JM. Heterogenous causes constituting the single syndrome of preeclampsia:A hypothesis and its implications. Am J Obstet Gynecol. 1996;175:1365-1370.
7. Gilbert RE, Marsden PhA. Activated protein C and diabetic nephropathy. N Engl J Med. 2008;358:1628-1630.
8. Hathaway W, Corrigan J. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis. Thromb Haemost. 1991;65:323-325.
9. Uszyński M, Żekanowska E, Kotzbach M, Uszyński W, Kotzbach R. Protein C, protein S, and thrombomodulin in amniotic fluid. J Perinat Med. 2006;34:289-292.
10. Uszyński W, Uszyński M, Zekanowska E. Thrombin activatable fibrinolysis inhibitor (TAFI) in human amniotic fluid. A preliminary study. Thromb Res. 2007;119:241-245.
11. Lao TTH, Yin JA, Yuen PMP. Coagulation and anticoagulation systems in newborns- correlation with their mothers at delivery. Lower levels of anticoagulants and fibrinolytic activity in the newborn. Gynecol Obstet Invest. 1990;29:181-184.
12. Gursoy T, Tekinalp G, Yiqit S, Kirazli S, Korkmaz A, Gurqey A. Thrombin activatable fibrinolysis inhibitor activity (TAFIa) levels in neonates with meconium-stained amniotic fluid. J Matern Fetal Neonatal Med. 2008;21:123-128.
13. Menashi S, Aurousseau MH, Gozin D, Daffos F, D'Angelo A, Forestier F, Boffa MC. High levels of circulating thrombomodulin in human foetuses and children. Thromb Haemost. 1999;81:906-909.
14. Orbe I, Paramo JA, Pinacho A, Hermida J, Rocha E. Plasma thrombomodulin is increased in cord blood of healthy newborns. Thromb Haemost. 1995;73:326.
15. Mosnier LO, Elisen MGLM, Bouma BN, Meijers JCM. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation. Thromb Haemost. 2001;86:1057-1064.
16. Mosnier LO, Meijers JCM, Bouma BN. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis. Thromb Haemost. 2001;86:1040-1046.
17. Schwarz HP, Muntean W, Watzke H, Richter B, Griffin JH. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood. 1988;71: 562-565.
18. Cvirin G, Koestenberger M, Leschnik B, Male Ch, Kutschera J, Fertl U, Muntean W, Juergens G, Gallistl S. Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults. Brit J Pharmacol. 2005;146:1082-1086.
19. Healy AM, Raybourn HB, Rosenberg RD, Weiler H. Absence of the blood - clotting regulator thrombomodulin causes embryonic lethality in nice before development of functional cardiovascular system. Proc Natl Acad Sci USA. 1995:92: 850-854.
20. Convay EM, Pollefeyt S, Cornelissen J, DeBaere I, Steiner- Mosonyi M, Weitz JI, Weiler-Guetler H, Carmeliet P, Collen D. Structure function analyses of thrombomodulin by genetargeting in mice: the cytoplasmic domain is not required for normal fetal development. Blood. 1999;93:3442-3450.